[go: up one dir, main page]

WO2000071105A3 - Tricloroacetic acid for the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions - Google Patents

Tricloroacetic acid for the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions Download PDF

Info

Publication number
WO2000071105A3
WO2000071105A3 PCT/EP2000/004680 EP0004680W WO0071105A3 WO 2000071105 A3 WO2000071105 A3 WO 2000071105A3 EP 0004680 W EP0004680 W EP 0004680W WO 0071105 A3 WO0071105 A3 WO 0071105A3
Authority
WO
WIPO (PCT)
Prior art keywords
erosive
compositions
solutions
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/004680
Other languages
French (fr)
Other versions
WO2000071105A2 (en
Inventor
Giorgio Mezzoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU49246/00A priority Critical patent/AU4924600A/en
Publication of WO2000071105A2 publication Critical patent/WO2000071105A2/en
Publication of WO2000071105A3 publication Critical patent/WO2000071105A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Meat, Egg Or Seafood Products (AREA)

Abstract

Use of trichloroacetic acid in the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions, in particular herpetic erosive lesions and/or aphthous ulcerative lesions.
PCT/EP2000/004680 1999-05-24 2000-05-23 Tricloroacetic acid for the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions Ceased WO2000071105A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU49246/00A AU4924600A (en) 1999-05-24 2000-05-23 Tricloroacetic acid for the preparation of solutions and/or compositions for thetreatment of erosive and/or ulcerative lesions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001144A IT1312313B1 (en) 1999-05-24 1999-05-24 TRICHLOROACETIC ACID FOR THE PREPARATION OF SOLUTIONS AND / OCOMPOSITIONS FOR THE TREATMENT OF EROSIVE AND / OR ULCERATIVE INJURIES.
ITMI99A001144 1999-05-24

Publications (2)

Publication Number Publication Date
WO2000071105A2 WO2000071105A2 (en) 2000-11-30
WO2000071105A3 true WO2000071105A3 (en) 2001-02-22

Family

ID=11383031

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/004680 Ceased WO2000071105A2 (en) 1999-05-24 2000-05-23 Tricloroacetic acid for the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions

Country Status (3)

Country Link
AU (1) AU4924600A (en)
IT (1) IT1312313B1 (en)
WO (1) WO2000071105A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128903B2 (en) 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
AU2012241013B2 (en) * 2011-04-04 2015-08-06 Environ Skin Care (Pty) Ltd The treatment of viral infections

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5611687A (en) * 1995-11-06 1997-03-18 Dental Concepts Inc. Oral hygiene delivery system
WO1997009963A1 (en) * 1995-09-15 1997-03-20 Obagi Zein E Skin peel maintenance composition and method
DE19627340A1 (en) * 1996-06-28 1998-01-02 Luyken Hans Thomas Dr drug

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009963A1 (en) * 1995-09-15 1997-03-20 Obagi Zein E Skin peel maintenance composition and method
US5611687A (en) * 1995-11-06 1997-03-18 Dental Concepts Inc. Oral hygiene delivery system
DE19627340A1 (en) * 1996-06-28 1998-01-02 Luyken Hans Thomas Dr drug

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Martindale, The Extra Pharmacopoeia", 1996, ROYAL PHARMACEUTICAL SOCIETY, LONDON UK, XP002152384 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; DYNIA J: "[Conservative treatment of vaginal portio erosion with trichloroacetic acid ]. Zachowawcze leczenie tzw. nadzerek czesci pochwowej szyjki macicy kwasem trojchlorooctowym.", XP002152385, retrieved from STN Database accession no. 78085688 *
DUCRUET L.: "[Recurrent aphtous stomatitis: Aetiology and treatment]. L' APHTOSE BUCCALE RECIDIVANTE: ETIOLOGIE ET TRAITEMENT.", LYON PHARMACEUTIQUE, (1997) 48/8 (408-412)., XP000961325 *
GINEKOLOGIA POLSKA, (1977 NOV) 48 (11) 997-1000. *
HEITHERSAY G S ET AL: "TISSUE RESPONSES IN THE RAT TO TRICHLOROACETIC ACID AN AGENT USED IN THE TREATMENT OF INVASIVE CERVICAL RESORPTION.", AUST DENT J, (1988) 33 (6), 451-461., XP000961327 *
IMBERT A L: "[Drepanocytic ulcers: contribution to the study of their treatment]. Ulc eres drepanocytaires: contribution a l'etude de leur traitement.", PHLEBOLOGIE, (1965 JUL-SEP) 18 (3) 275-81., XP000961331 *
OSBORNE N G ET AL: "Herpes simplex and human papillomavirus genital infections: controversy over obstetric management.", CLINICAL OBSTETRICS AND GYNECOLOGY, (1990 DEC) 33 (4) 801-11. REF: 20, XP000961322 *
SEDLACEK J: "[Cauterization of corneal herpetic diseases ufing trichloroacetic acid]. Kauterizace herpetickych onemocneni rohovky kyselinov trichloroctovou.", CESKOSLOVENSKA OFTALMOLOGIE, (1970 NOV) 26 (6) 373., XP000961333 *

Also Published As

Publication number Publication date
IT1312313B1 (en) 2002-04-15
ITMI991144A1 (en) 2000-11-24
AU4924600A (en) 2000-12-12
WO2000071105A2 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
AUPR105400A0 (en) Processes and compositions for water treatment
AU7490900A (en) Chemical compounds and compositions and their use as cathepsin s inhibitors
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001268659A1 (en) Water treatment compositions
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
AU2677899A (en) Polishing composition including water soluble polishing agent
AU2002227985A1 (en) Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
WO2002056915A3 (en) Complex of modafinil and cyclodextrin
AU2002241508A1 (en) Membrane derived caspase-3, compositions comprising the same and methods of use therefor
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
AU1887399A (en) Aqueous compositions comprising complexing agents and uses therof
CA2429639A1 (en) Stable azithromycin monohydrate
AU4996100A (en) (s,r) formoterol methods and compositions
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
AU2002213588A1 (en) Soluble cd1 compositions and uses thereof
AU7296200A (en) Cosmetic composition based on hardly or non-polymerised, water soluble and partly neutralised silicon organic compounds
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
WO2000071105A3 (en) Tricloroacetic acid for the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions
WO2000069841A3 (en) Benzofuranylaminoalcohols
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP